Integrated Multi‐Omics Analyses Reveal Causal DNA Methylation‐Breast Cancer Associations Mediated by Plasma Proteins
Journal of Cellular and Molecular Medicine · 2026-11 · 30 (21)
DOI: 10.1111/jcmm.71424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 08.11.2026. Verfasst von Wei Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Breast Surgery, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China. Hauptthemen laut MEDLINE: DNA Methylation, Breast Neoplasms, Blood Proteins. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Project for Leading Traditional Chinese Medicine Specialties, Henan Province Traditional Chinese Medicine Key Discipline Construction Project, Doctoral Research Foundation of the First Affiliated Hospital of Henan University of Chinese Medicine.
Abstract (Originalsprache)
Although aberrant DNA methylation is implicated in breast cancer (BC) pathogenesis, establishing causality is difficult and the downstream mediators are unclear. We investigated the causal role of blood DNA methylation and its proteomic mediators. Differentially methylated positions (DMPs) were identified from a genome‐wide blood methylation dataset, and two‐sample Mendelian randomization (MR) was performed using methylation quantitative trait loci for the significant DMPs together with BC genetic data from two independent consortia (FinnGen and the Breast Cancer Association Consortium), applying inverse‐variance weighted and generalized summary‐data‐based MR with validation by Bayesian colocalization and PheWAS. Proteome‐wide mediation and single‐cell RNA sequencing (scRNA‐seq) analyses explored downstream pathways. We identified 19,169 DMPs, and MR revealed 95 CpG sites with consistent, MR‐supported associations with BC. Meta‐analysis confirmed three high‐confidence loci (cg15146122, OR = 0.91; cg01529201, OR = 1.14; cg24704912, OR = 1.11), with colocalization support for two of them. Mediation analysis identified 203 BC ‐associated proteins, the three CpG sites influencing 41‐314 proteins involved in immune regulation, apoptosis and lysosomal pathways and scRNA‐seq localized the mediator proteins to specific cell populations of the tumour microenvironment. Blood DNA methylation is therefore associated with BC risk in an MR‐supported manner through specific plasma proteins, highlighting candidate epigenetic biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Breast Surgery, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China.
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
ORCID-Profile: Hanghang Chen
Förderung
- National Project for Leading Traditional Chinese Medicine Specialties
- Henan Province Traditional Chinese Medicine Key Discipline Construction Project
- Doctoral Research Foundation of the First Affiliated Hospital of Henan University of Chinese Medicine
Zitieren
APA
Wang, W., Cheng, Z., Liu, R., Cheng, X., & Chen, H. (2026). Integrated Multi‐Omics Analyses Reveal Causal DNA Methylation‐Breast Cancer Associations Mediated by Plasma Proteins. Journal of Cellular and Molecular Medicine, 30(21). https://doi.org/10.1111/jcmm.71424
Vancouver
Wang W, Cheng Z, Liu R, Cheng X, Chen H. Integrated Multi‐Omics Analyses Reveal Causal DNA Methylation‐Breast Cancer Associations Mediated by Plasma Proteins. Journal of Cellular and Molecular Medicine. 2026;30(21). doi:10.1111/jcmm.71424
BibTeX
@article{Wang2026,
author = {Wang, Wei and Cheng, Ziye and Liu, Ruidong and Cheng, Xufeng and Chen, Hanghang},
title = {Integrated Multi‐Omics Analyses Reveal Causal DNA Methylation‐Breast Cancer Associations Mediated by Plasma Proteins},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {21},
doi = {10.1111/jcmm.71424}
}
EUVIMED